National and Kapodistrian University of Athens
Επίδραση της οξείας (υπογλώσσιας) χορήγησης αναστολέως μετατρεπτικού ενζύμου της αγγειοτασίνης στο κολπικό νατριουρητικό πεπτίδιο σε υπερτασικούς ασθενείς με ή χωρίς μη ινσουλινοεξαρτώμενο σακχαρώδη διαβήτη: βιοχημικές και αιμοδυναμικές συσχετίσεις
Abstract
dc:descriptionWith the aim of evaluating the interaction and fluctuation of atrial natriuretic peptide (ANP) serum levels with clinical and biochemical parameters of hypertension, we studied 50 hypertensive patients, with or no diabetes mellitus – type 2, prior to and 2 hours following the sublingual administration of captopril (25mg). The blood pressure dropped significantly in all hypertensive patients, without any cardiac rate changes. A reduction of the ANP serum level was noted in the all the diabetic and the non diabetic hypertensives. The hypertensives who presented a reduction in the ANP levels had either hypertrophy of the left ventricle and relatively high plasma renin activity (PRA) levels, or were obese with relatively low plasma renin activity levels. The ANP serum levels remained unaffected in the normal weight patients. There was a decrease of the ANP serum levels in both hypertensives with or without microalbuminuria, without any comparable differentiation between those groups. The PRA increased clearly in the diabetics and the normal weight hypertensive patients. On the contrary the PRA remained unaffected in the non diabetics, in the obese hypertensives and in the hypertensives with LV hypertrophy or microalbuminuria. It is concluded from the present study that the sublingual administration of captopril remains effective in decreasing the ANP levels in the serum of hypertensive patients with or without type 2 diabetes mellitus, particularly in the renin-dependent hypertensives with LV hypertrophy. Perhaps the sublingual captopril administration would be of a particular clinical importance in patients with the reported clinical characteristics and under condition of hypertensive crisis, after subsequent elimination of ACE inhibition.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimitrelos, Evangelos
- Δημητρέλλος, Ευάγγελος
Subjects
dc:subject × 20- Υπέρταση
- Σακχαρώδης διαβήτης τύπου ΙΙ
- Κολπικό νατριουρητικό πεπτίδιο (ANP)
- Υπογλώσσια χορήγηση
- Αναστολέας μετατρεπτικού ενζύμου αγγειοτασίνης
- Υπερτροφία αριστεράς κοιλίας
- Μικροαλβουμινουρία
- Παχυσαρκία
- Hypertension
- Diabetes mellitus type II
- Atrial natriuretic peptide (ANP)
- Sublingual administration
- Angiotensin converting enzyme inhibitors
- Left ventricular hypertrophy
- Microalbuminuria
- Obesity
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22689